In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Epimmune licenses gene delivery technologies
Eurogene and Valentis initiate trial for prevention of blood vessel hyperplasia
Valentis issued patent for non-viral gene delivery technology
Valentis and Boehringer Ingelheim to collaborate on rheumatoid arthritis therapy
Valentis licenses delivery technology to Juvaris
Genencor's Technology for Production of Secreted Polypeptides Licensed by Pfizer
Valentis enters cross license agreement with Genzyme
Valentis initiates gene therapy clinical trial
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
